Stories

A replay with complete presentation and Q&A session will be made available soon after the Annual General Meeting.

New in our A Life in Science series, we hear from Elodie Lewkowicz, Asset Lead, about how curiosity and collaboration drive her mission to tackle the complexity of cancer. She reflects on mentoring, developing the next generation of scientists, and keeping patients at the heart of every data point to stay motivated through challenges.

The European Neuroendocrine Tumor Society (ENETS) 4 – 6 March 2026 conference in Kraków is one of the most important moments of the year for the global NET community. Clinicians, researchers, nurses, advocates and partners come together with a shared purpose to expand understanding of neuroendocrine tumors (NETs) and improve care for people living with them.

Every year, new breakthroughs reveal possibilities for treating conditions once thought untreatable. But possibility alone is not enough. The true challenge lies in identifying compelling scientific opportunities early—and shaping them deliberately so they can one day make a meaningful impact for patients. At Ipsen, we recognize the potential of early science; where bold ideas thrive and where there is the greatest risk but also the potential to change patients’ lives.

Rare Disease Day reminds us that rare conditions impact far more lives than many realize -over 300 million people globally, across more than 10,000 identified rare diseases. Yet what strikes me most on this day of recognition and reflection is that listening to patients remains an under-utilized lever for achieving progress in healthcare.